Loading
companiesCompany
German CLL Study Group
aka Deutsche CLL Studiengruppe, DCLLSG, GCLLSG
The German CLL Study Group, founded in 1996 at the University of Cologne, runs the numbered CLL trials that set first-line treatment of chronic lymphocytic leukaemia, including CLL12, CLL13 (GAIA) and CLL14 in OnCo.
Overview
The Deutsche CLL Studiengruppe (DCLLSG, German CLL Study Group) was founded in 1996 to improve the diagnosis and treatment of chronic lymphocytic leukaemia through controlled prospective trials, and describes itself as a research organisation of the University of Cologne specialising in CLL (dcllsg.de). ClinicalTrials.gov names it lead sponsor (OTHER class) of CLL12 (NCT02863718, phase 3, ibrutinib against placebo in early-stage CLL, with Janssen-Cilag as collaborator) and of CLL13 / GAIA (NCT02950051, phase 3, venetoclax combinations against chemoimmunotherapy in fit treatment-naive CLL, with Janssen-Cilag, Roche, AbbVie, HOVON, the Nordic CLL Study Group and others as collaborators); on CLL14 (NCT02242942, venetoclax and obinutuzumab in unfit CLL) the registry lead is Hoffmann-La Roche and the group is a collaborator, as the OnCo record's sponsor line says. It has no products of its own.
Similar pages
not linked directly; found by shared links- Key paperCLL12: ibrutinib in early-stage chronic lymphocytic leukaemia, a randomised placebo-controlled phase 3 trial
Shares CLL12, Chronic lymphocytic leukaemia, first treatment, Chronic lymphocytic leukaemia.
- PairingVenetoclax + obinutuzumab (12 months)
Shares CLL14, CLL13 / GAIA, Chronic lymphocytic leukaemia, first treatment, Chronic lymphocytic leukaemia.
- PersonMichael Hallek
Shares CLL14, CLL13 / GAIA, Chronic lymphocytic leukaemia.
- TermIGHV mutational status
Shares CLL13 / GAIA, Chronic lymphocytic leukaemia, first treatment, Chronic lymphocytic leukaemia.
- TrialSurovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin He
Shares Chronic lymphocytic leukaemia, first treatment, Chronic lymphocytic leukaemia.
- PersonBarbara Eichhorst
- Key paperCLL14: one year of venetoclax plus obinutuzumab instead of chemo-immunotherapy in older, less fit CLL patients
Shares CLL14, CLL13 / GAIA, Chronic lymphocytic leukaemia, first treatment, Chronic lymphocytic leukaemia.
- TermTumour lysis syndrome (TLS)
Shares CLL14, Chronic lymphocytic leukaemia, first treatment, Chronic lymphocytic leukaemia.